Science China Chemistry, Год журнала: 2023, Номер 67(3), С. 774 - 787
Опубликована: Окт. 23, 2023
Язык: Английский
Science China Chemistry, Год журнала: 2023, Номер 67(3), С. 774 - 787
Опубликована: Окт. 23, 2023
Язык: Английский
Chemical Society Reviews, Год журнала: 2023, Номер 52(13), С. 4392 - 4442
Опубликована: Янв. 1, 2023
Metal agents have made incredible strides in preclinical research and clinical applications, but their short emission/absorption wavelengths continue to be a barrier distribution, therapeutic action, visual tracking, efficacy evaluation.
Язык: Английский
Процитировано
92Journal of the American Chemical Society, Год журнала: 2024, Номер 146(13), С. 8991 - 9003
Опубликована: Март 21, 2024
Though immunogenic cell death (ICD) has garnered significant attention in the realm of anticancer therapies, effectively stimulating strong immune responses with minimal side effects deep-seated tumors remains challenging. Herein, we introduce a novel self-assembled near-infrared-light-activated ruthenium(II) metallacycle, Ru1105 (λem = 1105 nm), as first example Ru(II) supramolecular ICD inducer. synergistically potentiates immunomodulatory and reduces adverse through multiple regulated approaches, including NIR-light excitation, increased reactive oxygen species (ROS) generation, selective targeting tumor cells, precision organelle localization, improved penetration/retention capabilities. Specifically, demonstrates excellent depth-activated ROS production (∼1 cm), resistance to diffusion, anti-ROS quenching. Moreover, exhibits promising results cellular uptake generation cancer cells multicellular spheroids. Importantly, induces more efficient an ultralow dose (10 μM) compared conventional agent, oxaliplatin (300 μM). In vivo experiments further confirm Ru1105's potency inducer, eliciting CD8+ T depleting Foxp3+ effects. Our research lays foundation for design secure exceptionally potent metal-based agents immunotherapy.
Язык: Английский
Процитировано
47Coordination Chemistry Reviews, Год журнала: 2024, Номер 505, С. 215677 - 215677
Опубликована: Янв. 31, 2024
Язык: Английский
Процитировано
46Angewandte Chemie International Edition, Год журнала: 2024, Номер 63(15)
Опубликована: Фев. 8, 2024
Abstract Albeit sonodynamic therapy (SDT) has achieved encouraging progress in microbial sterilization, the scarcity of guidelines for designing highly effective sonosensitizers and intricate biofilm microenvironment (BME), substantially hamper therapeutic efficacy against infections. To address bottlenecks, we innovatively design a Ru(II) metallacycle‐based sonosensitizer/sonocatalyst (named Ru‐A3‐TTD ) to enhance potency sonotherapy by employing molecular engineering strategies tailored BME. Our approach involves augmenting ’s production ultrasonic‐triggered reactive oxygen species (ROS), surpassing performance commercial sonosensitizers, through straightforward but potent π‐expansion approach. Within BME, synergistically amplifies sonotherapeutic via triple‐modulated approaches: (i) alleviation hypoxia, leading increased ROS generation, (ii) disruption antioxidant defense system, which shields from glutathione consumption, (iii) enhanced penetration, enabling deep sites. Notably, sono‐catalytically oxidizes NADPH, critical coenzyme involved defenses. Consequently, demonstrates superior eradication multidrug‐resistant Escherichia coli compared conventional clinical antibiotics, both vitro vivo. our knowledge, this study represents pioneering instance supramolecular sonosensitizer/sonocatalyst. It provides valuable insights into structure‐activity relationship paves promising pathway treatment
Язык: Английский
Процитировано
34Chemical Society Reviews, Год журнала: 2024, Номер 53(6), С. 3167 - 3204
Опубликована: Янв. 1, 2024
We report strategies employed by metallacycle/metallacage-based supramolecular coordination complexes to enhance water solubility and biostability reduce potential toxicity side effects for biomedical applications.
Язык: Английский
Процитировано
31Science China Chemistry, Год журнала: 2024, Номер 67(5), С. 1397 - 1441
Опубликована: Март 22, 2024
Язык: Английский
Процитировано
30Chemical Science, Год журнала: 2024, Номер 15(5), С. 1870 - 1878
Опубликована: Янв. 1, 2024
We present an efficient method for the transformation of type II photosensitizers ( 1 O 2 ) into I (O ˙− through implementation artificial light-harvesting system involving a two-step sequential energy transfer process.
Язык: Английский
Процитировано
25Aggregate, Год журнала: 2024, Номер 5(2)
Опубликована: Янв. 4, 2024
Abstract The development of efficient drug delivery systems is essential for improving the efficacy and safety cancer drugs, particularly aggressive difficult‐to‐treat cancers. Covalent organic frameworks (COFs) are emerging as innovative porous nanomaterials in (DDS), due to their unique properties, including metal‐free skeleton, predetermined structures pore geometries, high porosity, large surface area, facile modification potential, good biocompatibility. These characteristics make COFs excellent candidates by enhancing loading capacity enabling precise encapsulation. This review emphasizes importance donor‐acceptor‐based COFs, which provide channels charge transportation, we also explore how π‐conjugated skeleton enhances its long‐acting fluorescent properties facilitates uptake via cell endocytosis. While this primarily focuses on recent advancements COF‐based targeted DDS, it acknowledges challenges posed diverse geometries materials discusses potential solutions. Further, underlines developing future carriers that can successfully specifically target cells, treatment efficiency while reducing adverse side effects.
Язык: Английский
Процитировано
20Journal of the American Chemical Society, Год журнала: 2025, Номер 147(2), С. 2010 - 2020
Опубликована: Янв. 7, 2025
Developing small organic molecular phototheranostic agents with second near-infrared (NIR-II) aggregation-induced emission (AIE) is paramount for the phototriggered diagnostic imaging and synchronous in situ therapy of cancer via an excellent balance excited states energy dissipations. In this study, a multifunctional iridium(III) complex exploited by coordination AIE-active N^N ancillary ligand trivalent iridium ion. The resultant DPTPzIr significantly outperforms its parent terms absorption/emission wavelengths, reactive oxygen species (ROS) production, photothermal conversion, which simultaneously endow nanoparticles matched absorption peak to commercial 808 nm laser, longest NIR-II (above 1100 nm) among those previously reported AIE complexes, potentiated type-I ROS generation, as high 60.5% conversion efficiency. Consequently, perform well multimodal image-guided photodynamic therapy-photothermal breast tumor-bearing mice, enabling precise tumor diagnosis complete ablation biocompatibility. Our present work provides simple, feasible, effective paradigm development advanced agents.
Язык: Английский
Процитировано
6Science China Chemistry, Год журнала: 2025, Номер unknown
Опубликована: Янв. 2, 2025
Язык: Английский
Процитировано
2